Ruxolitinib in the Treatment of Covid-19
NCT04414098
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
INC424 / Ruxolitinib
Sponsor
Marcelo Iastrebner
Collaborators
[object Object]